Skip to main content

Rural, regional & remote clinical trial support units

Improving access to innovative healthcare across NSW and ACT

Call for Expressions of Interest to establish three rural, regional and remote clinical trial support units opening early in the new year

As part of the Rural, Regional and Remote Clinical Trials Program, funded under the Medical Research Future Fund – Rural, Regional and Remote Clinical Trial Enabling Infrastructure Grant, NSW Health is planning to establish a network of three regional, rural and remote clinical trial support units (R3CTSUs) to deliver increased and more equitable access to clinical trials for patients in rural, regional and remote (R3) NSW.

The three R3CTSUs will be responsible for facilitating and delivering clinical trials across all NSW and ACT MMM3-7 populations, working with centralised functions led out of the NSW Ministry of Health, clinicaltrialsNSW.

NSW Ministry of Health invites local health districts (NSW) and health services (ACT) covering MMM3-7 populations to apply for funding to establish and implement a R3CTSU in one of three clusters – the northern, western or southern NSW/ACT cluster, which is representative of the local health districts (NSW)/health services (ACT) within these areas.

NSW Health will determine the funding amount awarded based on several factors, including but not limited to population size, clinical trial portfolio, perceived growth and clinical trial support unit staffing required.

Eligibility criteria

The Expression of Interest (EOI) must be led by a Research Director at an eligible host organisation or a clinical trials champion nominated by an eligible host organisation in collaboration with local health districts (NSW)/ health services (ACT) within the cluster. The Research Director or clinical trials champion will drive and oversee the development and operationalisation of the R3CTSU, reporting to clinicaltrialsNSW.

Eligible host organisations include:

  • NSW local health districts covering MMM3-7 populations
  • ACT health services supporting MMM3-7 populations.

The R3CTSU can be co-located across the local health districts (NSW)/ health services (ACT) covering the northern, western or southern NSW/ACT cluster.

The R3CTSU must service all local health districts (NSW)/ health services (ACT) within the cluster.

The NSW Ministry of Health will also be hosting webinars to support applicants in the EOI development phase.

More information

To receive updates on this funding opportunity including webinars, please subscribe to our email list and select the RRR Clinical Trial Program interest area. If you are already subscribed, please update your profile by adding the RRR Clinical Trial Program to your interest areas.

For further information or any questions, please contact Anita van der Meer, clinicaltrialsNSW Manager, at: Anita.VanDerMeer@health.nsw.gov.au

 

Updated 1 month ago